{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:41:06Z","timestamp":1779324066680,"version":"3.51.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T00:00:00Z","timestamp":1724803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","dldjournalonline.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.dld.2024.08.040","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T13:06:37Z","timestamp":1726751197000},"page":"241-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study"],"prefix":"10.1016","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2177-0421","authenticated-orcid":false,"given":"Emma","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Onali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Variola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9421-3087","authenticated-orcid":false,"given":"Davide Giuseppe","family":"Ribaldone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3187-2894","authenticated-orcid":false,"given":"Edoardo Vincenzo","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1733-6489","authenticated-orcid":false,"given":"Anna","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5677-2534","authenticated-orcid":false,"given":"Simone","family":"Saibeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Simone","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4328-5267","authenticated-orcid":false,"given":"Anna","family":"Testa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6341-5711","authenticated-orcid":false,"given":"Giovanni","family":"Latella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambrogio","family":"Orlando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariabeatrice","family":"Principi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8978-1661","authenticated-orcid":false,"given":"Antonino Carlo","family":"Privitera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giammarco","family":"Mocci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Boy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Adelaide","family":"Piccarozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuliana","family":"Gualberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Marando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5982-0122","authenticated-orcid":false,"given":"Lorenzo","family":"Gemignani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2024.08.040_bib0001","first-page":"14","article-title":"Ulcerative colitis and Crohn's disease have similar burden and goals for treatment","volume":"18","author":"Le Berre","year":"2020","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.08.040_bib0002","first-page":"343","article-title":"Natural history of adult ulcerative colitis in population-based cohorts: a systematic review","volume":"16","author":"Fumery","year":"2018","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.08.040_bib0003","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.dld.2024.08.040_bib0004","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on Inflammatory Bowel Disease and Malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0005","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1053\/j.gastro.2021.08.032","article-title":"Prevalence of primary sclerosing cholangitis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"161","author":"Barberio","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.08.040_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ijcard.2023.01.071","article-title":"Myocarditis and inflammatory bowel diseases: a single-center experience and a systematic literature review","volume":"376","author":"Giordani","year":"2023","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.dld.2024.08.040_bib0007","doi-asserted-by":"crossref","first-page":"5548","DOI":"10.3390\/jcm10235548","article-title":"Journey through Crohn's disease complication: from fistula formation to future therapies","volume":"10","author":"Rubbino","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.dld.2024.08.040_bib0008","first-page":"1899","article-title":"Incidence of and risk factors for colorectal strictures in ulcerative colitis: a multicenter study","volume":"19","author":"Laurain","year":"2021","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.dld.2024.08.040_bib0009","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.dld.2024.08.040_bib0010","doi-asserted-by":"crossref","first-page":"5862","DOI":"10.3748\/wjg.v25.i38.5862","article-title":"Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil","volume":"25","author":"Parra","year":"2019","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.040_bib0011","first-page":"274","article-title":"Prevalence of bowel damage assessed by cross-sectional imaging in early Crohn's disease and its impact on disease outcome","volume":"11","author":"Fiorino","year":"2017","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/5354320","article-title":"Factors influencing disability and quality of life during treatment: a cross-sectional study on IBD patients","volume":"2019","author":"Marinelli","year":"2019","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.dld.2024.08.040_bib0013","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1093\/ecco-jcc\/jjz131","article-title":"Outcomes and strategies to support a treat-to-target approach in inflammatory bowel disease: a systematic review","volume":"14","author":"Colombel","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1031998","article-title":"Personalize, participate, predict, and prevent: 4Ps in inflammatory bowel disease","volume":"10","author":"Lenti","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.dld.2024.08.040_bib0015","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dld.2024.08.040_bib0016","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/ajg.2015.233","article-title":"Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target","volume":"110","author":"Peyrin-Biroulet","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.040_bib0017","doi-asserted-by":"crossref","first-page":"113","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian","year":"2019","journal-title":"J Med Life"},{"key":"10.1016\/j.dld.2024.08.040_bib0018","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.dld.2024.08.040_bib0019","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/ecco-jcc\/jjz187","article-title":"ECCO Guidelines on therapeutics in Crohn's disease: surgical treatment","volume":"14","author":"Adamina","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment","volume":"16","author":"Spinelli","year":"2022","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0021","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/S0140-6736(17)32641-7","article-title":"Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial","volume":"390","author":"Colombel","year":"2017","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.dld.2024.08.040_bib0022","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S2468-1253(21)00474-X","article-title":"Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial","volume":"7","author":"Danese","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.040_bib0023","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.3748\/wjg.v27.i23.3396","article-title":"Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil","volume":"27","author":"Sassaki","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.040_bib0024","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s12325-023-02473-6","article-title":"Epidemiological, clinical, patient-reported and economic burden of inflammatory bowel disease (ulcerative colitis and Crohn's disease) in Spain: a systematic review","volume":"40","author":"Barreiro-de Acosta","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.dld.2024.08.040_bib0025","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ibd.20520","article-title":"Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis","volume":"14","author":"Lewis","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.dld.2024.08.040_bib0026","doi-asserted-by":"crossref","DOI":"10.1002\/ueg2.12572","article-title":"Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study","author":"D'Amico","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2024.08.040_bib0027","first-page":"53","article-title":"The use of fecal calprotectin in inflammatory bowel disease","volume":"13","author":"Bjarnason","year":"2017","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.040_bib0028","doi-asserted-by":"crossref","first-page":"e206","DOI":"10.1016\/j.crohns.2012.09.010","article-title":"Inflammatory bowel disease and pregnancy: lack of knowledge is associated with negative views","volume":"7","author":"Selinger","year":"2013","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0029","article-title":"CADTH canadian drug expert committee final recommendation infliximab: (Inflectra \u2014 Hospira Healthcare Corporation): indications: crohn disease and ulcerative colitis","author":"Anon","year":"2017","journal-title":"Ottawa (ON): Canadian Agency Drugs Technol Health"},{"key":"10.1016\/j.dld.2024.08.040_bib0030","first-page":"1571","article-title":"The short inflammatory bowel disease questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn's relapse prevention trial","volume":"91","author":"Irvine","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.040_bib0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3748\/wjg.v27.i2.208","article-title":"Real-world disease activity and sociodemographic, clinical and treatment characteristics of moderate-to-severe inflammatory bowel disease in Brazil","volume":"27","author":"Zaltman","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.040_bib0032","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1177\/2050640619852532","article-title":"Health-related quality of life in inflammatory bowel disease in a Danish population-based inception cohort","volume":"7","author":"Christiansen","year":"2019","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.dld.2024.08.040_bib0033","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00535-023-01958-z","article-title":"Treatment escalation and de-escalation decisions in Crohn's disease: delphi consensus recommendations from Japan, 2021","volume":"58","author":"Nakase","year":"2023","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.dld.2024.08.040_bib0034","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.3390\/biomedicines11051408","article-title":"The utility of faecal calprotectin, lactoferrin and other faecal biomarkers in discriminating endoscopic activity in Crohn's disease: a systematic review and meta-analysis","volume":"11","author":"Bohra","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.dld.2024.08.040_bib0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrgastro.2013.241","article-title":"Clinical implications of ageing for the management of IBD","volume":"11","author":"Ha","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.dld.2024.08.040_bib0036","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4291\/wjgp.v6.i1.13","article-title":"Laboratory markers in ulcerative colitis: current insights and future advances","volume":"6","author":"Cioffi","year":"2015","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/j.dld.2024.08.040_bib0037","first-page":"1450","article-title":"Corticosteroid use in patients with inflammatory bowel diseases: a real-life sub-analysis of the Italian DICE study","volume":"55","author":"Conforti","year":"2023","journal-title":"Dig Liver Dis Off J Ital Soc Gastroenterol Ital Assoc Study Liver"},{"key":"10.1016\/j.dld.2024.08.040_bib0038","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn's disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J Crohns Colitis"},{"key":"10.1016\/j.dld.2024.08.040_bib0039","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/apt.14334","article-title":"A multi-centre audit of excess steroid use in 1176 patients with inflammatory bowel disease","volume":"46","author":"Selinger","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.08.040_bib0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/apt.15497","article-title":"Assessment of steroid use as a key performance indicator in inflammatory bowel disease-analysis of data from 2385 UK patients","volume":"50","author":"Selinger","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.dld.2024.08.040_bib0041","first-page":"49","volume":"28","author":"Goran","year":"2021","journal-title":"Med Mod - Mod Med"},{"key":"10.1016\/j.dld.2024.08.040_bib0042","first-page":"jjad108","article-title":"ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease","author":"Gordon","year":"2023","journal-title":"J Crohns Colitis"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824009575?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865824009575?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T01:50:11Z","timestamp":1735782611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865824009575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1590865824009575"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.040","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2024.08.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd on behalf of Editrice Gastroenterologica Italiana S.r.l.","name":"copyright","label":"Copyright"}]}}